BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Regulus receives intellectual property license to modulate microRNAs
April 1, 2011
Liver-targeted SCD inhibitor from Merck & Co. shows improved tolerability
April 1, 2011
Eli Lilly launches Axiron topical testosterone replacement therapy in the U.S.
March 31, 2011
Betulin shows potential for the treatment of metabolic syndrome
March 31, 2011
Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes
March 31, 2011
New azacyclic HSL inhibitors claimed by Roche for diabetes and related disorders
March 30, 2011
Roche prepares novel compounds that inhibit beta-secretase for diabetes
March 30, 2011
GSK patents new AMPK activators
March 29, 2011
Tarsa's oral calcitonin meets primary endpoint in pivotal trial
March 28, 2011
Oramed Pharmaceuticals completes toxicity study for oral insulin capsule
March 25, 2011
Previous
1
2
…
631
632
633
634
635
636
637
638
639
…
1792
1793
Next
RSS